Australia markets closed

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.2100+0.1400 (+4.56%)
At close: 04:00PM EDT
3.1983 -0.01 (-0.36%)
After hours: 07:59PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
26,285
30,776
109,282
52,251
-
Other short-term investments
99,718
116,137
46,035
71,017
-
Total cash
126,003
146,913
155,317
123,268
-
Net receivables
1,776
1,352
899
1,312
-
Other current assets
4,248
2,874
4,445
-
-
Total current assets
132,027
151,139
160,661
127,704
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
17,990
17,615
17,449
16,953
-
Accumulated depreciation
-11,900
-10,801
-9,374
-7,621
-
Net property, plant and equipment
6,090
6,814
8,075
9,332
-
Equity and other investments
6,284
37,363
35,688
0
-
Goodwill
-
-
-
-
0
Other long-term assets
-
103
61
44
293
Total non-current assets
12,374
44,280
43,824
9,376
-
Total assets
144,401
195,419
204,485
137,080
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
3,223
3,520
3,174
2,994
-
Accrued liabilities
7,048
12,509
7,664
5,907
-
Deferred revenues
11,791
16,456
0
-
-
Other current liabilities
-
-
26
250
253
Total current liabilities
22,487
32,857
11,221
9,541
-
Non-current liabilities
Deferred tax liabilities
-
-
-
-
0
Deferred revenues
0
5,999
0
-
18,992
Other long-term liabilities
14,553
17,896
21,594
22,980
-
Total non-current liabilities
15,896
25,710
23,825
25,573
-
Total liabilities
38,383
58,567
35,046
35,114
-
Stockholders' equity
Common stock
1,349,821
1,318,737
1,286,636
1,135,347
-
Retained earnings
-1,276,652
-1,203,803
-1,134,347
-1,045,961
-
Accumulated other comprehensive income
-48,421
-50,488
-48,335
-48,171
-
Total stockholders' equity
106,018
136,852
169,439
101,966
-
Total liabilities and stockholders' equity
144,401
195,419
204,485
137,080
-